Copyright Reports & Markets. All rights reserved.

Global Levonorgestrel API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Levonorgestrel API Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Short-Acting Contraceptive API
    • 1.3.3 Long-Acting Contraceptive API
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Levonorgestrel API Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Levonorgestrel Tablet
    • 1.4.3 Mixture Products
    • 1.4.4 Hormone-releasing IUD
  • 1.5 Global Levonorgestrel API Market Size & Forecast
    • 1.5.1 Global Levonorgestrel API Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Levonorgestrel API Sales Quantity (2019-2030)
    • 1.5.3 Global Levonorgestrel API Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Bayer HealthCare
    • 2.1.1 Bayer HealthCare Details
    • 2.1.2 Bayer HealthCare Major Business
    • 2.1.3 Bayer HealthCare Levonorgestrel API Product and Services
    • 2.1.4 Bayer HealthCare Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bayer HealthCare Recent Developments/Updates
  • 2.2 Qinhuangdao Zizhu Pharmaceutical
    • 2.2.1 Qinhuangdao Zizhu Pharmaceutical Details
    • 2.2.2 Qinhuangdao Zizhu Pharmaceutical Major Business
    • 2.2.3 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Product and Services
    • 2.2.4 Qinhuangdao Zizhu Pharmaceutical Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Qinhuangdao Zizhu Pharmaceutical Recent Developments/Updates
  • 2.3 Yangzhou Pharmaceutical
    • 2.3.1 Yangzhou Pharmaceutical Details
    • 2.3.2 Yangzhou Pharmaceutical Major Business
    • 2.3.3 Yangzhou Pharmaceutical Levonorgestrel API Product and Services
    • 2.3.4 Yangzhou Pharmaceutical Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Yangzhou Pharmaceutical Recent Developments/Updates
  • 2.4 Lupin
    • 2.4.1 Lupin Details
    • 2.4.2 Lupin Major Business
    • 2.4.3 Lupin Levonorgestrel API Product and Services
    • 2.4.4 Lupin Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Lupin Recent Developments/Updates
  • 2.5 Hubei Gedian Humanwell
    • 2.5.1 Hubei Gedian Humanwell Details
    • 2.5.2 Hubei Gedian Humanwell Major Business
    • 2.5.3 Hubei Gedian Humanwell Levonorgestrel API Product and Services
    • 2.5.4 Hubei Gedian Humanwell Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Hubei Gedian Humanwell Recent Developments/Updates
  • 2.6 Sterling Spa
    • 2.6.1 Sterling Spa Details
    • 2.6.2 Sterling Spa Major Business
    • 2.6.3 Sterling Spa Levonorgestrel API Product and Services
    • 2.6.4 Sterling Spa Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Sterling Spa Recent Developments/Updates
  • 2.7 Formos
    • 2.7.1 Formos Details
    • 2.7.2 Formos Major Business
    • 2.7.3 Formos Levonorgestrel API Product and Services
    • 2.7.4 Formos Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Formos Recent Developments/Updates
  • 2.8 Huazhong Pharm
    • 2.8.1 Huazhong Pharm Details
    • 2.8.2 Huazhong Pharm Major Business
    • 2.8.3 Huazhong Pharm Levonorgestrel API Product and Services
    • 2.8.4 Huazhong Pharm Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Huazhong Pharm Recent Developments/Updates
  • 2.9 ASG Biochem
    • 2.9.1 ASG Biochem Details
    • 2.9.2 ASG Biochem Major Business
    • 2.9.3 ASG Biochem Levonorgestrel API Product and Services
    • 2.9.4 ASG Biochem Levonorgestrel API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 ASG Biochem Recent Developments/Updates

3 Competitive Environment: Levonorgestrel API by Manufacturer

  • 3.1 Global Levonorgestrel API Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Levonorgestrel API Revenue by Manufacturer (2019-2024)
  • 3.3 Global Levonorgestrel API Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Levonorgestrel API by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Levonorgestrel API Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Levonorgestrel API Manufacturer Market Share in 2023
  • 3.5 Levonorgestrel API Market: Overall Company Footprint Analysis
    • 3.5.1 Levonorgestrel API Market: Region Footprint
    • 3.5.2 Levonorgestrel API Market: Company Product Type Footprint
    • 3.5.3 Levonorgestrel API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Levonorgestrel API Market Size by Region
    • 4.1.1 Global Levonorgestrel API Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Levonorgestrel API Consumption Value by Region (2019-2030)
    • 4.1.3 Global Levonorgestrel API Average Price by Region (2019-2030)
  • 4.2 North America Levonorgestrel API Consumption Value (2019-2030)
  • 4.3 Europe Levonorgestrel API Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Levonorgestrel API Consumption Value (2019-2030)
  • 4.5 South America Levonorgestrel API Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Levonorgestrel API Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 5.2 Global Levonorgestrel API Consumption Value by Type (2019-2030)
  • 5.3 Global Levonorgestrel API Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 6.2 Global Levonorgestrel API Consumption Value by Application (2019-2030)
  • 6.3 Global Levonorgestrel API Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 7.2 North America Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 7.3 North America Levonorgestrel API Market Size by Country
    • 7.3.1 North America Levonorgestrel API Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Levonorgestrel API Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 8.2 Europe Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 8.3 Europe Levonorgestrel API Market Size by Country
    • 8.3.1 Europe Levonorgestrel API Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Levonorgestrel API Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Levonorgestrel API Market Size by Region
    • 9.3.1 Asia-Pacific Levonorgestrel API Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Levonorgestrel API Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 10.2 South America Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 10.3 South America Levonorgestrel API Market Size by Country
    • 10.3.1 South America Levonorgestrel API Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Levonorgestrel API Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Levonorgestrel API Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Levonorgestrel API Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Levonorgestrel API Market Size by Country
    • 11.3.1 Middle East & Africa Levonorgestrel API Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Levonorgestrel API Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Levonorgestrel API Market Drivers
  • 12.2 Levonorgestrel API Market Restraints
  • 12.3 Levonorgestrel API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Levonorgestrel API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Levonorgestrel API
  • 13.3 Levonorgestrel API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Levonorgestrel API Typical Distributors
  • 14.3 Levonorgestrel API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Levonorgestrel is a hormonal medication which is used in a number of birth control methods.
    According to our (Global Info Research) latest study, the global Levonorgestrel API market size was valued at US$ 51.5 million in 2023 and is forecast to a readjusted size of USD 67.2 million by 2030 with a CAGR of 3.9% during review period.
    By type, the Global Levonorgestrel API market share is the highest in the short-acting contraceptive API, about 67.17%. The most proportion of the Global Levonorgestrel API market share is used for Levonorgestrel Tablet and the proportion is about 52.74% in 2020.
    This report is a detailed and comprehensive analysis for global Levonorgestrel API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Levonorgestrel API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/KG), 2019-2030
    Global Levonorgestrel API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/KG), 2019-2030
    Global Levonorgestrel API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/KG), 2019-2030
    Global Levonorgestrel API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/KG), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Levonorgestrel API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Levonorgestrel API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer HealthCare, Qinhuangdao Zizhu Pharmaceutical, Yangzhou Pharmaceutical, Lupin, Hubei Gedian Humanwell, Sterling Spa, Formos, Huazhong Pharm, ASG Biochem, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Levonorgestrel API market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Short-Acting Contraceptive API
    Long-Acting Contraceptive API
    Market segment by Application
    Levonorgestrel Tablet
    Mixture Products
    Hormone-releasing IUD
    Major players covered
    Bayer HealthCare
    Qinhuangdao Zizhu Pharmaceutical
    Yangzhou Pharmaceutical
    Lupin
    Hubei Gedian Humanwell
    Sterling Spa
    Formos
    Huazhong Pharm
    ASG Biochem
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Levonorgestrel API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Levonorgestrel API, with price, sales quantity, revenue, and global market share of Levonorgestrel API from 2019 to 2024.
    Chapter 3, the Levonorgestrel API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Levonorgestrel API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Levonorgestrel API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Levonorgestrel API.
    Chapter 14 and 15, to describe Levonorgestrel API sales channel, distributors, customers, research findings and conclusion.

    Buy now